▶ 調査レポート

世界の体外がん検診検査キット市場インサイト・予測(~2027年)

• 英文タイトル:Global In-Vitro Cancer Screening Tests Kits Market Insights and Forecast to 2027

QYResearchが調査・発行した産業分析レポートです。世界の体外がん検診検査キット市場インサイト・予測(~2027年) / Global In-Vitro Cancer Screening Tests Kits Market Insights and Forecast to 2027 / QY2108PAL3576資料のイメージです。• レポートコード:QY2108PAL3576
• 出版社/出版日:QYResearch / 2021年8月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、112ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User¥725,200 (USD4,900)▷ お問い合わせ
  Multi User¥1,087,800 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査資料は体外がん検診検査キットの世界市場の現状について調査・分析し、2027年までの市場を予測しました。体外がん検診検査キットの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模(結腸直腸がん、卵巣がん、非小細胞肺がん、黒色腫、乳がん、その他)、用途別市場規模(病院・クリニック、歩行用、在宅医療)、主要地域別市場規模(北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ)、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。

・体外がん検診検査キットの世界市場概要
・メーカー別の競争状況、市場シェア
・体外がん検診検査キットの種類別市場規模:結腸直腸がん、卵巣がん、非小細胞肺がん、黒色腫、乳がん、その他
・体外がん検診検査キットの用途別市場規模:病院・クリニック、歩行用、在宅医療
・北米の体外がん検診検査キット市場規模2016-2027:種類別、用途別、国別(アメリカ、カナダ)
・ヨーロッパの体外がん検診検査キット市場規模2016-2027:種類別、用途別、国別(ドイツ、フランス、イギリス)
・アジアの体外がん検診検査キット市場規模2016-2027:種類別、用途別、国別(日本、中国、インド、韓国)
・中南米の体外がん検診検査キット市場規模2016-2027:種類別、用途別、国別(メキシコ、ブラジル)
・中東・アフリカの体外がん検診検査キット市場規模2016-2027:種類別、用途別、国別(トルコ、サウジアラビア)
・企業情報:Alere(Abbott)、Beckman Coulter、Siemens Healthcare、Eiken Chemical、Hitachi Chemical (Kyowa Medex)、Clinical Genomics Pty Ltd (Quest Diagnostics)、Sysmex、QIAGEN、R-Biopharm、Immunostics、Roche
・体外がん検診検査キットのバリューチェーン・販売チャネル分析
・体外がん検診検査キットの世界市場動向

Market Analysis and Insights: Global In-Vitro Cancer Screening Tests Kits Market
The global In-Vitro Cancer Screening Tests Kits market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global In-Vitro Cancer Screening Tests Kits Scope and Segment
In-Vitro Cancer Screening Tests Kits market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global In-Vitro Cancer Screening Tests Kits market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Colorectal Cancer
Ovarian Cancer
Non-Small Cell Lung Cancer
Melanoma
Breast Cancer
Other

Segment by Application
Hospital and Clinics
Ambulatory
Home Care

By Company
Alere(Abbott)
Beckman Coulter
Siemens Healthcare
Eiken Chemical
Hitachi Chemical (Kyowa Medex)
Clinical Genomics Pty Ltd (Quest Diagnostics)
Sysmex
QIAGEN
R-Biopharm
Immunostics
Roche

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 In-Vitro Cancer Screening Tests Kits Product Introduction
1.2 Market by Type
1.2.1 Global In-Vitro Cancer Screening Tests Kits Market Size Growth Rate by Type
1.2.2 Colorectal Cancer
1.2.3 Ovarian Cancer
1.2.4 Non-Small Cell Lung Cancer
1.2.5 Melanoma
1.2.6 Breast Cancer
1.2.7 Other
1.3 Market by Application
1.3.1 Global In-Vitro Cancer Screening Tests Kits Market Size Growth Rate by Application
1.3.2 Hospital and Clinics
1.3.3 Ambulatory
1.3.4 Home Care
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global In-Vitro Cancer Screening Tests Kits Sales Estimates and Forecasts 2016-2027
2.2 Global In-Vitro Cancer Screening Tests Kits Revenue Estimates and Forecasts 2016-2027
2.3 Global In-Vitro Cancer Screening Tests Kits Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top In-Vitro Cancer Screening Tests Kits Regions by Sales
2.4.1 Global Top In-Vitro Cancer Screening Tests Kits Regions by Sales (2016-2021)
2.4.2 Global Top In-Vitro Cancer Screening Tests Kits Regions by Sales (2022-2027)
2.5 Global Top In-Vitro Cancer Screening Tests Kits Regions by Revenue
2.5.1 Global Top In-Vitro Cancer Screening Tests Kits Regions by Revenue (2016-2021)
2.5.2 Global Top In-Vitro Cancer Screening Tests Kits Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers
3.1 Global In-Vitro Cancer Screening Tests Kits Sales by Manufacturers
3.1.1 Global Top In-Vitro Cancer Screening Tests Kits Manufacturers by Sales (2016-2021)
3.1.2 Global Top In-Vitro Cancer Screening Tests Kits Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by In-Vitro Cancer Screening Tests Kits Sales in 2020
3.2 Global In-Vitro Cancer Screening Tests Kits Revenue by Manufacturers
3.2.1 Global Top In-Vitro Cancer Screening Tests Kits Manufacturers by Revenue (2016-2021)
3.2.2 Global Top In-Vitro Cancer Screening Tests Kits Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by In-Vitro Cancer Screening Tests Kits Revenue in 2020
3.3 Global In-Vitro Cancer Screening Tests Kits Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global In-Vitro Cancer Screening Tests Kits Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global In-Vitro Cancer Screening Tests Kits Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global In-Vitro Cancer Screening Tests Kits Sales by Type
4.1.1 Global In-Vitro Cancer Screening Tests Kits Historical Sales by Type (2016-2021)
4.1.2 Global In-Vitro Cancer Screening Tests Kits Forecasted Sales by Type (2022-2027)
4.1.3 Global In-Vitro Cancer Screening Tests Kits Sales Market Share by Type (2016-2027)
4.2 Global In-Vitro Cancer Screening Tests Kits Revenue by Type
4.2.1 Global In-Vitro Cancer Screening Tests Kits Historical Revenue by Type (2016-2021)
4.2.2 Global In-Vitro Cancer Screening Tests Kits Forecasted Revenue by Type (2022-2027)
4.2.3 Global In-Vitro Cancer Screening Tests Kits Revenue Market Share by Type (2016-2027)
4.3 Global In-Vitro Cancer Screening Tests Kits Price by Type
4.3.1 Global In-Vitro Cancer Screening Tests Kits Price by Type (2016-2021)
4.3.2 Global In-Vitro Cancer Screening Tests Kits Price Forecast by Type (2022-2027)

5 Market Size by Application
5.1 Global In-Vitro Cancer Screening Tests Kits Sales by Application
5.1.1 Global In-Vitro Cancer Screening Tests Kits Historical Sales by Application (2016-2021)
5.1.2 Global In-Vitro Cancer Screening Tests Kits Forecasted Sales by Application (2022-2027)
5.1.3 Global In-Vitro Cancer Screening Tests Kits Sales Market Share by Application (2016-2027)
5.2 Global In-Vitro Cancer Screening Tests Kits Revenue by Application
5.2.1 Global In-Vitro Cancer Screening Tests Kits Historical Revenue by Application (2016-2021)
5.2.2 Global In-Vitro Cancer Screening Tests Kits Forecasted Revenue by Application (2022-2027)
5.2.3 Global In-Vitro Cancer Screening Tests Kits Revenue Market Share by Application (2016-2027)
5.3 Global In-Vitro Cancer Screening Tests Kits Price by Application
5.3.1 Global In-Vitro Cancer Screening Tests Kits Price by Application (2016-2021)
5.3.2 Global In-Vitro Cancer Screening Tests Kits Price Forecast by Application (2022-2027)

6 North America
6.1 North America In-Vitro Cancer Screening Tests Kits Market Size by Type
6.1.1 North America In-Vitro Cancer Screening Tests Kits Sales by Type (2016-2027)
6.1.2 North America In-Vitro Cancer Screening Tests Kits Revenue by Type (2016-2027)
6.2 North America In-Vitro Cancer Screening Tests Kits Market Size by Application
6.2.1 North America In-Vitro Cancer Screening Tests Kits Sales by Application (2016-2027)
6.2.2 North America In-Vitro Cancer Screening Tests Kits Revenue by Application (2016-2027)
6.3 North America In-Vitro Cancer Screening Tests Kits Market Size by Country
6.3.1 North America In-Vitro Cancer Screening Tests Kits Sales by Country (2016-2027)
6.3.2 North America In-Vitro Cancer Screening Tests Kits Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada

7 Europe
7.1 Europe In-Vitro Cancer Screening Tests Kits Market Size by Type
7.1.1 Europe In-Vitro Cancer Screening Tests Kits Sales by Type (2016-2027)
7.1.2 Europe In-Vitro Cancer Screening Tests Kits Revenue by Type (2016-2027)
7.2 Europe In-Vitro Cancer Screening Tests Kits Market Size by Application
7.2.1 Europe In-Vitro Cancer Screening Tests Kits Sales by Application (2016-2027)
7.2.2 Europe In-Vitro Cancer Screening Tests Kits Revenue by Application (2016-2027)
7.3 Europe In-Vitro Cancer Screening Tests Kits Market Size by Country
7.3.1 Europe In-Vitro Cancer Screening Tests Kits Sales by Country (2016-2027)
7.3.2 Europe In-Vitro Cancer Screening Tests Kits Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia

8 Asia Pacific
8.1 Asia Pacific In-Vitro Cancer Screening Tests Kits Market Size by Type
8.1.1 Asia Pacific In-Vitro Cancer Screening Tests Kits Sales by Type (2016-2027)
8.1.2 Asia Pacific In-Vitro Cancer Screening Tests Kits Revenue by Type (2016-2027)
8.2 Asia Pacific In-Vitro Cancer Screening Tests Kits Market Size by Application
8.2.1 Asia Pacific In-Vitro Cancer Screening Tests Kits Sales by Application (2016-2027)
8.2.2 Asia Pacific In-Vitro Cancer Screening Tests Kits Revenue by Application (2016-2027)
8.3 Asia Pacific In-Vitro Cancer Screening Tests Kits Market Size by Region
8.3.1 Asia Pacific In-Vitro Cancer Screening Tests Kits Sales by Region (2016-2027)
8.3.2 Asia Pacific In-Vitro Cancer Screening Tests Kits Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia

9 Latin America
9.1 Latin America In-Vitro Cancer Screening Tests Kits Market Size by Type
9.1.1 Latin America In-Vitro Cancer Screening Tests Kits Sales by Type (2016-2027)
9.1.2 Latin America In-Vitro Cancer Screening Tests Kits Revenue by Type (2016-2027)
9.2 Latin America In-Vitro Cancer Screening Tests Kits Market Size by Application
9.2.1 Latin America In-Vitro Cancer Screening Tests Kits Sales by Application (2016-2027)
9.2.2 Latin America In-Vitro Cancer Screening Tests Kits Revenue by Application (2016-2027)
9.3 Latin America In-Vitro Cancer Screening Tests Kits Market Size by Country
9.3.1 Latin America In-Vitro Cancer Screening Tests Kits Sales by Country (2016-2027)
9.3.2 Latin America In-Vitro Cancer Screening Tests Kits Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa In-Vitro Cancer Screening Tests Kits Market Size by Type
10.1.1 Middle East and Africa In-Vitro Cancer Screening Tests Kits Sales by Type (2016-2027)
10.1.2 Middle East and Africa In-Vitro Cancer Screening Tests Kits Revenue by Type (2016-2027)
10.2 Middle East and Africa In-Vitro Cancer Screening Tests Kits Market Size by Application
10.2.1 Middle East and Africa In-Vitro Cancer Screening Tests Kits Sales by Application (2016-2027)
10.2.2 Middle East and Africa In-Vitro Cancer Screening Tests Kits Revenue by Application (2016-2027)
10.3 Middle East and Africa In-Vitro Cancer Screening Tests Kits Market Size by Country
10.3.1 Middle East and Africa In-Vitro Cancer Screening Tests Kits Sales by Country (2016-2027)
10.3.2 Middle East and Africa In-Vitro Cancer Screening Tests Kits Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia

11 Company Profiles
11.1 Alere(Abbott)
11.1.1 Alere(Abbott) Corporation Information
11.1.2 Alere(Abbott) Overview
11.1.3 Alere(Abbott) In-Vitro Cancer Screening Tests Kits Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Alere(Abbott) In-Vitro Cancer Screening Tests Kits Product Description
11.1.5 Alere(Abbott) Recent Developments
11.2 Beckman Coulter
11.2.1 Beckman Coulter Corporation Information
11.2.2 Beckman Coulter Overview
11.2.3 Beckman Coulter In-Vitro Cancer Screening Tests Kits Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Beckman Coulter In-Vitro Cancer Screening Tests Kits Product Description
11.2.5 Beckman Coulter Recent Developments
11.3 Siemens Healthcare
11.3.1 Siemens Healthcare Corporation Information
11.3.2 Siemens Healthcare Overview
11.3.3 Siemens Healthcare In-Vitro Cancer Screening Tests Kits Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Siemens Healthcare In-Vitro Cancer Screening Tests Kits Product Description
11.3.5 Siemens Healthcare Recent Developments
11.4 Eiken Chemical
11.4.1 Eiken Chemical Corporation Information
11.4.2 Eiken Chemical Overview
11.4.3 Eiken Chemical In-Vitro Cancer Screening Tests Kits Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Eiken Chemical In-Vitro Cancer Screening Tests Kits Product Description
11.4.5 Eiken Chemical Recent Developments
11.5 Hitachi Chemical (Kyowa Medex)
11.5.1 Hitachi Chemical (Kyowa Medex) Corporation Information
11.5.2 Hitachi Chemical (Kyowa Medex) Overview
11.5.3 Hitachi Chemical (Kyowa Medex) In-Vitro Cancer Screening Tests Kits Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Hitachi Chemical (Kyowa Medex) In-Vitro Cancer Screening Tests Kits Product Description
11.5.5 Hitachi Chemical (Kyowa Medex) Recent Developments
11.6 Clinical Genomics Pty Ltd (Quest Diagnostics)
11.6.1 Clinical Genomics Pty Ltd (Quest Diagnostics) Corporation Information
11.6.2 Clinical Genomics Pty Ltd (Quest Diagnostics) Overview
11.6.3 Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Cancer Screening Tests Kits Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Cancer Screening Tests Kits Product Description
11.6.5 Clinical Genomics Pty Ltd (Quest Diagnostics) Recent Developments
11.7 Sysmex
11.7.1 Sysmex Corporation Information
11.7.2 Sysmex Overview
11.7.3 Sysmex In-Vitro Cancer Screening Tests Kits Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Sysmex In-Vitro Cancer Screening Tests Kits Product Description
11.7.5 Sysmex Recent Developments
11.8 QIAGEN
11.8.1 QIAGEN Corporation Information
11.8.2 QIAGEN Overview
11.8.3 QIAGEN In-Vitro Cancer Screening Tests Kits Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 QIAGEN In-Vitro Cancer Screening Tests Kits Product Description
11.8.5 QIAGEN Recent Developments
11.9 R-Biopharm
11.9.1 R-Biopharm Corporation Information
11.9.2 R-Biopharm Overview
11.9.3 R-Biopharm In-Vitro Cancer Screening Tests Kits Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 R-Biopharm In-Vitro Cancer Screening Tests Kits Product Description
11.9.5 R-Biopharm Recent Developments
11.10 Immunostics
11.10.1 Immunostics Corporation Information
11.10.2 Immunostics Overview
11.10.3 Immunostics In-Vitro Cancer Screening Tests Kits Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Immunostics In-Vitro Cancer Screening Tests Kits Product Description
11.10.5 Immunostics Recent Developments
11.11 Roche
11.11.1 Roche Corporation Information
11.11.2 Roche Overview
11.11.3 Roche In-Vitro Cancer Screening Tests Kits Sales, Price, Revenue and Gross Margin (2016-2021)
11.11.4 Roche In-Vitro Cancer Screening Tests Kits Product Description
11.11.5 Roche Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 In-Vitro Cancer Screening Tests Kits Value Chain Analysis
12.2 In-Vitro Cancer Screening Tests Kits Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 In-Vitro Cancer Screening Tests Kits Production Mode & Process
12.4 In-Vitro Cancer Screening Tests Kits Sales and Marketing
12.4.1 In-Vitro Cancer Screening Tests Kits Sales Channels
12.4.2 In-Vitro Cancer Screening Tests Kits Distributors
12.5 In-Vitro Cancer Screening Tests Kits Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 In-Vitro Cancer Screening Tests Kits Industry Trends
13.2 In-Vitro Cancer Screening Tests Kits Market Drivers
13.3 In-Vitro Cancer Screening Tests Kits Market Challenges
13.4 In-Vitro Cancer Screening Tests Kits Market Restraints

14 Key Findings in The Global In-Vitro Cancer Screening Tests Kits Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global In-Vitro Cancer Screening Tests Kits Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Colorectal Cancer
Table 3. Major Manufacturers of Ovarian Cancer
Table 4. Major Manufacturers of Non-Small Cell Lung Cancer
Table 5. Major Manufacturers of Melanoma
Table 6. Major Manufacturers of Breast Cancer
Table 7. Major Manufacturers of Other
Table 8. Global In-Vitro Cancer Screening Tests Kits Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 9. Global In-Vitro Cancer Screening Tests Kits Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 10. Global In-Vitro Cancer Screening Tests Kits Sales by Region (2016-2021) & (K Units)
Table 11. Global In-Vitro Cancer Screening Tests Kits Sales Market Share by Region (2016-2021)
Table 12. Global In-Vitro Cancer Screening Tests Kits Sales by Region (2022-2027) & (K Units)
Table 13. Global In-Vitro Cancer Screening Tests Kits Sales Market Share by Region (2022-2027)
Table 14. Global In-Vitro Cancer Screening Tests Kits Revenue by Region (2016-2021) & (US$ Million)
Table 15. Global In-Vitro Cancer Screening Tests Kits Revenue Market Share by Region (2016-2021)
Table 16. Global In-Vitro Cancer Screening Tests Kits Revenue by Region (2022-2027) & (US$ Million)
Table 17. Global In-Vitro Cancer Screening Tests Kits Revenue Market Share by Region (2022-2027)
Table 18. Global In-Vitro Cancer Screening Tests Kits Sales by Manufacturers (2016-2021) & (K Units)
Table 19. Global In-Vitro Cancer Screening Tests Kits Sales Share by Manufacturers (2016-2021)
Table 20. Global In-Vitro Cancer Screening Tests Kits Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 21. Global In-Vitro Cancer Screening Tests Kits Revenue Share by Manufacturers (2016-2021)
Table 22. In-Vitro Cancer Screening Tests Kits Price by Manufacturers 2016-2021 (US$/Unit)
Table 23. Global In-Vitro Cancer Screening Tests Kits Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global In-Vitro Cancer Screening Tests Kits by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Vitro Cancer Screening Tests Kits as of 2020)
Table 25. In-Vitro Cancer Screening Tests Kits Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers In-Vitro Cancer Screening Tests Kits Product Offered
Table 27. Date of Manufacturers Enter into In-Vitro Cancer Screening Tests Kits Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global In-Vitro Cancer Screening Tests Kits Sales by Type (2016-2021) & (K Units)
Table 30. Global In-Vitro Cancer Screening Tests Kits Sales by Type (2022-2027) & (K Units)
Table 31. Global In-Vitro Cancer Screening Tests Kits Sales Share by Type (2016-2021)
Table 32. Global In-Vitro Cancer Screening Tests Kits Sales Share by Type (2022-2027)
Table 33. Global In-Vitro Cancer Screening Tests Kits Revenue by Type (2016-2021) & (US$ Million)
Table 34. Global In-Vitro Cancer Screening Tests Kits Revenue by Type (2022-2027) & (US$ Million)
Table 35. Global In-Vitro Cancer Screening Tests Kits Revenue Share by Type (2016-2021)
Table 36. Global In-Vitro Cancer Screening Tests Kits Revenue Share by Type (2022-2027)
Table 37. In-Vitro Cancer Screening Tests Kits Price by Type (2016-2021) & (US$/Unit)
Table 38. Global In-Vitro Cancer Screening Tests Kits Price Forecast by Type (2022-2027) & (US$/Unit)
Table 39. Global In-Vitro Cancer Screening Tests Kits Sales by Application (2016-2021) & (K Units)
Table 40. Global In-Vitro Cancer Screening Tests Kits Sales by Application (2022-2027) & (K Units)
Table 41. Global In-Vitro Cancer Screening Tests Kits Sales Share by Application (2016-2021)
Table 42. Global In-Vitro Cancer Screening Tests Kits Sales Share by Application (2022-2027)
Table 43. Global In-Vitro Cancer Screening Tests Kits Revenue by Application (2016-2021) & (US$ Million)
Table 44. Global In-Vitro Cancer Screening Tests Kits Revenue by Application (2022-2027) & (US$ Million)
Table 45. Global In-Vitro Cancer Screening Tests Kits Revenue Share by Application (2016-2021)
Table 46. Global In-Vitro Cancer Screening Tests Kits Revenue Share by Application (2022-2027)
Table 47. In-Vitro Cancer Screening Tests Kits Price by Application (2016-2021) & (US$/Unit)
Table 48. Global In-Vitro Cancer Screening Tests Kits Price Forecast by Application (2022-2027) & (US$/Unit)
Table 49. North America In-Vitro Cancer Screening Tests Kits Sales by Type (2016-2021) & (K Units)
Table 50. North America In-Vitro Cancer Screening Tests Kits Sales by Type (2022-2027) & (K Units)
Table 51. North America In-Vitro Cancer Screening Tests Kits Revenue by Type (2016-2021) & (US$ Million)
Table 52. North America In-Vitro Cancer Screening Tests Kits Revenue by Type (2022-2027) & (US$ Million)
Table 53. North America In-Vitro Cancer Screening Tests Kits Sales by Application (2016-2021) & (K Units)
Table 54. North America In-Vitro Cancer Screening Tests Kits Sales by Application (2022-2027) & (K Units)
Table 55. North America In-Vitro Cancer Screening Tests Kits Revenue by Application (2016-2021) & (US$ Million)
Table 56. North America In-Vitro Cancer Screening Tests Kits Revenue by Application (2022-2027) & (US$ Million)
Table 57. North America In-Vitro Cancer Screening Tests Kits Sales by Country (2016-2021) & (K Units)
Table 58. North America In-Vitro Cancer Screening Tests Kits Sales by Country (2022-2027) & (K Units)
Table 59. North America In-Vitro Cancer Screening Tests Kits Revenue by Country (2016-2021) & (US$ Million)
Table 60. North America In-Vitro Cancer Screening Tests Kits Revenue by Country (2022-2027) & (US$ Million)
Table 61. Europe In-Vitro Cancer Screening Tests Kits Sales by Type (2016-2021) & (K Units)
Table 62. Europe In-Vitro Cancer Screening Tests Kits Sales by Type (2022-2027) & (K Units)
Table 63. Europe In-Vitro Cancer Screening Tests Kits Revenue by Type (2016-2021) & (US$ Million)
Table 64. Europe In-Vitro Cancer Screening Tests Kits Revenue by Type (2022-2027) & (US$ Million)
Table 65. Europe In-Vitro Cancer Screening Tests Kits Sales by Application (2016-2021) & (K Units)
Table 66. Europe In-Vitro Cancer Screening Tests Kits Sales by Application (2022-2027) & (K Units)
Table 67. Europe In-Vitro Cancer Screening Tests Kits Revenue by Application (2016-2021) & (US$ Million)
Table 68. Europe In-Vitro Cancer Screening Tests Kits Revenue by Application (2022-2027) & (US$ Million)
Table 69. Europe In-Vitro Cancer Screening Tests Kits Sales by Country (2016-2021) & (K Units)
Table 70. Europe In-Vitro Cancer Screening Tests Kits Sales by Country (2022-2027) & (K Units)
Table 71. Europe In-Vitro Cancer Screening Tests Kits Revenue by Country (2016-2021) & (US$ Million)
Table 72. Europe In-Vitro Cancer Screening Tests Kits Revenue by Country (2022-2027) & (US$ Million)
Table 73. Asia Pacific In-Vitro Cancer Screening Tests Kits Sales by Type (2016-2021) & (K Units)
Table 74. Asia Pacific In-Vitro Cancer Screening Tests Kits Sales by Type (2022-2027) & (K Units)
Table 75. Asia Pacific In-Vitro Cancer Screening Tests Kits Revenue by Type (2016-2021) & (US$ Million)
Table 76. Asia Pacific In-Vitro Cancer Screening Tests Kits Revenue by Type (2022-2027) & (US$ Million)
Table 77. Asia Pacific In-Vitro Cancer Screening Tests Kits Sales by Application (2016-2021) & (K Units)
Table 78. Asia Pacific In-Vitro Cancer Screening Tests Kits Sales by Application (2022-2027) & (K Units)
Table 79. Asia Pacific In-Vitro Cancer Screening Tests Kits Revenue by Application (2016-2021) & (US$ Million)
Table 80. Asia Pacific In-Vitro Cancer Screening Tests Kits Revenue by Application (2022-2027) & (US$ Million)
Table 81. Asia Pacific In-Vitro Cancer Screening Tests Kits Sales by Region (2016-2021) & (K Units)
Table 82. Asia Pacific In-Vitro Cancer Screening Tests Kits Sales by Region (2022-2027) & (K Units)
Table 83. Asia Pacific In-Vitro Cancer Screening Tests Kits Revenue by Region (2016-2021) & (US$ Million)
Table 84. Asia Pacific In-Vitro Cancer Screening Tests Kits Revenue by Region (2022-2027) & (US$ Million)
Table 85. Latin America In-Vitro Cancer Screening Tests Kits Sales by Type (2016-2021) & (K Units)
Table 86. Latin America In-Vitro Cancer Screening Tests Kits Sales by Type (2022-2027) & (K Units)
Table 87. Latin America In-Vitro Cancer Screening Tests Kits Revenue by Type (2016-2021) & (US$ Million)
Table 88. Latin America In-Vitro Cancer Screening Tests Kits Revenue by Type (2022-2027) & (US$ Million)
Table 89. Latin America In-Vitro Cancer Screening Tests Kits Sales by Application (2016-2021) & (K Units)
Table 90. Latin America In-Vitro Cancer Screening Tests Kits Sales by Application (2022-2027) & (K Units)
Table 91. Latin America In-Vitro Cancer Screening Tests Kits Revenue by Application (2016-2021) & (US$ Million)
Table 92. Latin America In-Vitro Cancer Screening Tests Kits Revenue by Application (2022-2027) & (US$ Million)
Table 93. Latin America In-Vitro Cancer Screening Tests Kits Sales by Country (2016-2021) & (K Units)
Table 94. Latin America In-Vitro Cancer Screening Tests Kits Sales by Country (2022-2027) & (K Units)
Table 95. Latin America In-Vitro Cancer Screening Tests Kits Revenue by Country (2016-2021) & (US$ Million)
Table 96. Latin America In-Vitro Cancer Screening Tests Kits Revenue by Country (2022-2027) & (US$ Million)
Table 97. Middle East and Africa In-Vitro Cancer Screening Tests Kits Sales by Type (2016-2021) & (K Units)
Table 98. Middle East and Africa In-Vitro Cancer Screening Tests Kits Sales by Type (2022-2027) & (K Units)
Table 99. Middle East and Africa In-Vitro Cancer Screening Tests Kits Revenue by Type (2016-2021) & (US$ Million)
Table 100. Middle East and Africa In-Vitro Cancer Screening Tests Kits Revenue by Type (2022-2027) & (US$ Million)
Table 101. Middle East and Africa In-Vitro Cancer Screening Tests Kits Sales by Application (2016-2021) & (K Units)
Table 102. Middle East and Africa In-Vitro Cancer Screening Tests Kits Sales by Application (2022-2027) & (K Units)
Table 103. Middle East and Africa In-Vitro Cancer Screening Tests Kits Revenue by Application (2016-2021) & (US$ Million)
Table 104. Middle East and Africa In-Vitro Cancer Screening Tests Kits Revenue by Application (2022-2027) & (US$ Million)
Table 105. Middle East and Africa In-Vitro Cancer Screening Tests Kits Sales by Country (2016-2021) & (K Units)
Table 106. Middle East and Africa In-Vitro Cancer Screening Tests Kits Sales by Country (2022-2027) & (K Units)
Table 107. Middle East and Africa In-Vitro Cancer Screening Tests Kits Revenue by Country (2016-2021) & (US$ Million)
Table 108. Middle East and Africa In-Vitro Cancer Screening Tests Kits Revenue by Country (2022-2027) & (US$ Million)
Table 109. Alere(Abbott) Corporation Information
Table 110. Alere(Abbott) Description and Major Businesses
Table 111. Alere(Abbott) In-Vitro Cancer Screening Tests Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 112. Alere(Abbott) In-Vitro Cancer Screening Tests Kits Product
Table 113. Alere(Abbott) Recent Developments
Table 114. Beckman Coulter Corporation Information
Table 115. Beckman Coulter Description and Major Businesses
Table 116. Beckman Coulter In-Vitro Cancer Screening Tests Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 117. Beckman Coulter In-Vitro Cancer Screening Tests Kits Product
Table 118. Beckman Coulter Recent Developments
Table 119. Siemens Healthcare Corporation Information
Table 120. Siemens Healthcare Description and Major Businesses
Table 121. Siemens Healthcare In-Vitro Cancer Screening Tests Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 122. Siemens Healthcare In-Vitro Cancer Screening Tests Kits Product
Table 123. Siemens Healthcare Recent Developments
Table 124. Eiken Chemical Corporation Information
Table 125. Eiken Chemical Description and Major Businesses
Table 126. Eiken Chemical In-Vitro Cancer Screening Tests Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 127. Eiken Chemical In-Vitro Cancer Screening Tests Kits Product
Table 128. Eiken Chemical Recent Developments
Table 129. Hitachi Chemical (Kyowa Medex) Corporation Information
Table 130. Hitachi Chemical (Kyowa Medex) Description and Major Businesses
Table 131. Hitachi Chemical (Kyowa Medex) In-Vitro Cancer Screening Tests Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 132. Hitachi Chemical (Kyowa Medex) In-Vitro Cancer Screening Tests Kits Product
Table 133. Hitachi Chemical (Kyowa Medex) Recent Developments
Table 134. Clinical Genomics Pty Ltd (Quest Diagnostics) Corporation Information
Table 135. Clinical Genomics Pty Ltd (Quest Diagnostics) Description and Major Businesses
Table 136. Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Cancer Screening Tests Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 137. Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Cancer Screening Tests Kits Product
Table 138. Clinical Genomics Pty Ltd (Quest Diagnostics) Recent Developments
Table 139. Sysmex Corporation Information
Table 140. Sysmex Description and Major Businesses
Table 141. Sysmex In-Vitro Cancer Screening Tests Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 142. Sysmex In-Vitro Cancer Screening Tests Kits Product
Table 143. Sysmex Recent Developments
Table 144. QIAGEN Corporation Information
Table 145. QIAGEN Description and Major Businesses
Table 146. QIAGEN In-Vitro Cancer Screening Tests Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 147. QIAGEN In-Vitro Cancer Screening Tests Kits Product
Table 148. QIAGEN Recent Developments
Table 149. R-Biopharm Corporation Information
Table 150. R-Biopharm Description and Major Businesses
Table 151. R-Biopharm In-Vitro Cancer Screening Tests Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 152. R-Biopharm In-Vitro Cancer Screening Tests Kits Product
Table 153. R-Biopharm Recent Developments
Table 154. Immunostics Corporation Information
Table 155. Immunostics Description and Major Businesses
Table 156. Immunostics In-Vitro Cancer Screening Tests Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 157. Immunostics In-Vitro Cancer Screening Tests Kits Product
Table 158. Immunostics Recent Developments
Table 159. Roche Corporation Information
Table 160. Roche Description and Major Businesses
Table 161. Roche In-Vitro Cancer Screening Tests Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 162. Roche In-Vitro Cancer Screening Tests Kits Product
Table 163. Roche Recent Developments
Table 164. Key Raw Materials Lists
Table 165. Raw Materials Key Suppliers Lists
Table 166. In-Vitro Cancer Screening Tests Kits Distributors List
Table 167. In-Vitro Cancer Screening Tests Kits Customers List
Table 168. In-Vitro Cancer Screening Tests Kits Market Trends
Table 169. In-Vitro Cancer Screening Tests Kits Market Drivers
Table 170. In-Vitro Cancer Screening Tests Kits Market Challenges
Table 171. In-Vitro Cancer Screening Tests Kits Market Restraints
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. In-Vitro Cancer Screening Tests Kits Product Picture
Figure 2. Global In-Vitro Cancer Screening Tests Kits Market Share by Type in 2020 & 2027
Figure 3. Colorectal Cancer Product Picture
Figure 4. Ovarian Cancer Product Picture
Figure 5. Non-Small Cell Lung Cancer Product Picture
Figure 6. Melanoma Product Picture
Figure 7. Breast Cancer Product Picture
Figure 8. Other Product Picture
Figure 9. Global In-Vitro Cancer Screening Tests Kits Market Share by Application in 2020 & 2027
Figure 10. Hospital and Clinics
Figure 11. Ambulatory
Figure 12. Home Care
Figure 13. In-Vitro Cancer Screening Tests Kits Report Years Considered
Figure 14. Global In-Vitro Cancer Screening Tests Kits Sales 2016-2027 (K Units)
Figure 15. Global In-Vitro Cancer Screening Tests Kits Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global In-Vitro Cancer Screening Tests Kits Revenue 2016-2027 (US$ Million)
Figure 17. Global In-Vitro Cancer Screening Tests Kits Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 18. Global In-Vitro Cancer Screening Tests Kits Sales Market Share by Region (2016-2021)
Figure 19. Global In-Vitro Cancer Screening Tests Kits Sales Market Share by Region (2022-2027)
Figure 20. North America In-Vitro Cancer Screening Tests Kits Sales YoY (2016-2027) & (K Units)
Figure 21. North America In-Vitro Cancer Screening Tests Kits Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Europe In-Vitro Cancer Screening Tests Kits Sales YoY (2016-2027) & (K Units)
Figure 23. Europe In-Vitro Cancer Screening Tests Kits Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Asia-Pacific In-Vitro Cancer Screening Tests Kits Sales YoY (2016-2027) & (K Units)
Figure 25. Asia-Pacific In-Vitro Cancer Screening Tests Kits Revenue YoY (2016-2027) & (US$ Million)
Figure 26. Latin America In-Vitro Cancer Screening Tests Kits Sales YoY (2016-2027) & (K Units)
Figure 27. Latin America In-Vitro Cancer Screening Tests Kits Revenue YoY (2016-2027) & (US$ Million)
Figure 28. Middle East & Africa In-Vitro Cancer Screening Tests Kits Sales YoY (2016-2027) & (K Units)
Figure 29. Middle East & Africa In-Vitro Cancer Screening Tests Kits Revenue YoY (2016-2027) & (US$ Million)
Figure 30. The Top 10 and Top 5 Players Market Share by In-Vitro Cancer Screening Tests Kits Sales in 2020
Figure 31. The Top 10 and Top 5 Players Market Share by In-Vitro Cancer Screening Tests Kits Revenue in 2020
Figure 32. In-Vitro Cancer Screening Tests Kits Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 33. Global In-Vitro Cancer Screening Tests Kits Sales Market Share by Type (2016-2027)
Figure 34. Global In-Vitro Cancer Screening Tests Kits Revenue Market Share by Type (2016-2027)
Figure 35. Global In-Vitro Cancer Screening Tests Kits Sales Market Share by Application (2016-2027)
Figure 36. Global In-Vitro Cancer Screening Tests Kits Revenue Market Share by Application (2016-2027)
Figure 37. North America In-Vitro Cancer Screening Tests Kits Sales Market Share by Type (2016-2027)
Figure 38. North America In-Vitro Cancer Screening Tests Kits Revenue Market Share by Type (2016-2027)
Figure 39. North America In-Vitro Cancer Screening Tests Kits Sales Market Share by Application (2016-2027)
Figure 40. North America In-Vitro Cancer Screening Tests Kits Revenue Market Share by Application (2016-2027)
Figure 41. North America In-Vitro Cancer Screening Tests Kits Sales Share by Country (2016-2027)
Figure 42. North America In-Vitro Cancer Screening Tests Kits Revenue Share by Country (2016-2027)
Figure 43. United States In-Vitro Cancer Screening Tests Kits Revenue (2016-2027) & (US$ Million)
Figure 44. Canada In-Vitro Cancer Screening Tests Kits Revenue (2016-2027) & (US$ Million)
Figure 45. Europe In-Vitro Cancer Screening Tests Kits Sales Market Share by Type (2016-2027)
Figure 46. Europe In-Vitro Cancer Screening Tests Kits Revenue Market Share by Type (2016-2027)
Figure 47. Europe In-Vitro Cancer Screening Tests Kits Sales Market Share by Application (2016-2027)
Figure 48. Europe In-Vitro Cancer Screening Tests Kits Revenue Market Share by Application (2016-2027)
Figure 49. Europe In-Vitro Cancer Screening Tests Kits Sales Share by Country (2016-2027)
Figure 50. Europe In-Vitro Cancer Screening Tests Kits Revenue Share by Country (2016-2027)
Figure 51. Germany In-Vitro Cancer Screening Tests Kits Revenue (2016-2027) & (US$ Million)
Figure 52. France In-Vitro Cancer Screening Tests Kits Revenue (2016-2027) & (US$ Million)
Figure 53. U.K. In-Vitro Cancer Screening Tests Kits Revenue (2016-2027) & (US$ Million)
Figure 54. Italy In-Vitro Cancer Screening Tests Kits Revenue (2016-2027) & (US$ Million)
Figure 55. Russia In-Vitro Cancer Screening Tests Kits Revenue (2016-2027) & (US$ Million)
Figure 56. Asia Pacific In-Vitro Cancer Screening Tests Kits Sales Market Share by Type (2016-2027)
Figure 57. Asia Pacific In-Vitro Cancer Screening Tests Kits Revenue Market Share by Type (2016-2027)
Figure 58. Asia Pacific In-Vitro Cancer Screening Tests Kits Sales Market Share by Application (2016-2027)
Figure 59. Asia Pacific In-Vitro Cancer Screening Tests Kits Revenue Market Share by Application (2016-2027)
Figure 60. Asia Pacific In-Vitro Cancer Screening Tests Kits Sales Share by Region (2016-2027)
Figure 61. Asia Pacific In-Vitro Cancer Screening Tests Kits Revenue Share by Region (2016-2027)
Figure 62. China In-Vitro Cancer Screening Tests Kits Revenue (2016-2027) & (US$ Million)
Figure 63. Japan In-Vitro Cancer Screening Tests Kits Revenue (2016-2027) & (US$ Million)
Figure 64. South Korea In-Vitro Cancer Screening Tests Kits Revenue (2016-2027) & (US$ Million)
Figure 65. India In-Vitro Cancer Screening Tests Kits Revenue (2016-2027) & (US$ Million)
Figure 66. Australia In-Vitro Cancer Screening Tests Kits Revenue (2016-2027) & (US$ Million)
Figure 67. Taiwan In-Vitro Cancer Screening Tests Kits Revenue (2016-2027) & (US$ Million)
Figure 68. Indonesia In-Vitro Cancer Screening Tests Kits Revenue (2016-2027) & (US$ Million)
Figure 69. Thailand In-Vitro Cancer Screening Tests Kits Revenue (2016-2027) & (US$ Million)
Figure 70. Malaysia In-Vitro Cancer Screening Tests Kits Revenue (2016-2027) & (US$ Million)
Figure 71. Latin America In-Vitro Cancer Screening Tests Kits Sales Market Share by Type (2016-2027)
Figure 72. Latin America In-Vitro Cancer Screening Tests Kits Revenue Market Share by Type (2016-2027)
Figure 73. Latin America In-Vitro Cancer Screening Tests Kits Sales Market Share by Application (2016-2027)
Figure 74. Latin America In-Vitro Cancer Screening Tests Kits Revenue Market Share by Application (2016-2027)
Figure 75. Latin America In-Vitro Cancer Screening Tests Kits Sales Share by Country (2016-2027)
Figure 76. Latin America In-Vitro Cancer Screening Tests Kits Revenue Share by Country (2016-2027)
Figure 77. Mexico In-Vitro Cancer Screening Tests Kits Revenue (2016-2027) & (US$ Million)
Figure 78. Brazil In-Vitro Cancer Screening Tests Kits Revenue (2016-2027) & (US$ Million)
Figure 79. Argentina In-Vitro Cancer Screening Tests Kits Revenue (2016-2027) & (US$ Million)
Figure 80. Middle East and Africa In-Vitro Cancer Screening Tests Kits Sales Market Share by Type (2016-2027)
Figure 81. Middle East and Africa In-Vitro Cancer Screening Tests Kits Revenue Market Share by Type (2016-2027)
Figure 82. Middle East and Africa In-Vitro Cancer Screening Tests Kits Sales Market Share by Application (2016-2027)
Figure 83. Middle East and Africa In-Vitro Cancer Screening Tests Kits Revenue Market Share by Application (2016-2027)
Figure 84. Middle East and Africa In-Vitro Cancer Screening Tests Kits Sales Share by Country (2016-2027)
Figure 85. Middle East and Africa In-Vitro Cancer Screening Tests Kits Revenue Share by Country (2016-2027)
Figure 86. Turkey In-Vitro Cancer Screening Tests Kits Revenue (2016-2027) & (US$ Million)
Figure 87. Saudi Arabia In-Vitro Cancer Screening Tests Kits Revenue (2016-2027) & (US$ Million)
Figure 88. UAE In-Vitro Cancer Screening Tests Kits Revenue (2016-2027) & (US$ Million)
Figure 89. In-Vitro Cancer Screening Tests Kits Value Chain
Figure 90. In-Vitro Cancer Screening Tests Kits Production Process
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed